RNA interference (RNAi) is a collection of small RNA directed mechanisms that result in sequence specific inhibition of gene expression. The notion that RNAi could lead to a new class of therapeutics caught the attention of many investigators soon after its discovery. The field of applied RNAi therapeutics has moved very quickly from lab to bedside. The RNAi approach has been widely used for drug development and several phase I and II clinical trials are under way. However, there are still some concerns and challenges to overcome for therapeutic applications. These include the potential for off-target effects, triggering innate immune responses and most importantly obtaining specific delivery into the cytoplasm of target cells.
The RNAi for Therapeutic market revenue was xx Million USD in 2016, grew to xx Million USD in 2020, and will reach xx Million USD in 2026, with a CAGR of xx during 2020-2026.
Global RNAi for Therapeutic Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries covers and analyzes the potential of the global RNAi for Therapeutic industry, providing statistical information about market dynamics, growth factors, major challenges, PEST analysis and market entry strategy Analysis, opportunities and forecasts. The biggest highlight of the report is to provide companies in the industry with a strategic analysis of the impact of COVID-19. At the same time, this report analyzed the market of leading 20 countries and introduce the market potential of these countries.
Major Players in RNAi for Therapeutic market are:
Benitec Biopharma
AstraZeneca
Bayer Heathcare
Ensysce Biosciences
Ascletis Pharmaceuticals
Tekmira Pharmaceuticals.
GeneCopoeia
Celgene
Biogazelle
RXi Pharmaceuticals
Roche Innovation Center Copenhagen (formerly Santaris Pharma)
Celsion Corporation
Arrowhead Research
Gradalis Incorporated
Silenseed
Astellas Pharma
Silence Therapeutics
Quark Pharmaceuticals
BioSpring
Creative Animodel
Sylentis
Calando Pharmaceuticals
CombiMatrix
Alnylam Pharmaceuticals
Most important types of RNAi for Therapeutic products covered in this report are:
siRNA
miRNA
shRNA
Most widely used downstream fields of RNAi for Therapeutic market covered in this report are:
Cancer
Cardiovascular
HBV
Others
Top countries data covered in this report:
United States
Canada
Germany
UK
France
Italy
Spain
Russia
China
Japan
South Korea
Australia
Thailand
Brazil
Argentina
Chile
South Africa
Egypt
UAE
Saudi Arabia
Chapter 1 is the basis of the entire report. In this chapter, we define the market concept and market scope of RNAi for Therapeutic, including product classification, application areas, and the entire report covered area.
Chapter 2 is the core idea of the whole report. In this chapter, we provide a detailed introduction to our research methods and data sources.
Chapter 3 focuses on analyzing the current competitive situation in the RNAi for Therapeutic market and provides basic information, market data, product introductions, etc. of leading companies in the industry. At the same time, Chapter 3 includes the highlighted analysis--Strategies for Company to Deal with the Impact of COVID-19.
Chapter 4 provides breakdown data of different types of products, as well as market forecasts.
Different application fields have different usage and development prospects of products. Therefore, Chapter 5 provides subdivision data of different application fields and market forecasts.
Chapter 6 includes detailed data of major regions of the world, including detailed data of major regions of the world. North America, Asia Pacific, Europe, South America, Middle East and Africa.
Chapters 7-26 focus on the regional market. We have selected the most representative 20 countries from 197 countries in the world and conducted a detailed analysis and overview of the market development of these countries.
Chapter 27 focuses on market qualitative analysis, providing market driving factor analysis, market development constraints, PEST analysis, industry trends under COVID-19, market entry strategy analysis, etc.
Key Points:
Define, describe and forecast RNAi for Therapeutic product market by type, application, end user and region.
Provide enterprise external environment analysis and PEST analysis.
Provide strategies for company to deal with the impact of COVID-19.
Provide market dynamic analysis, including market driving factors, market development constraints.
Provide market entry strategy analysis for new players or players who are ready to enter the market, including market segment definition, client analysis, distribution model, product messaging and positioning, and price strategy analysis.
Keep up with international market trends and provide analysis of the impact of the COVID-19 epidemic on major regions of the world.
Analyze the market opportunities of stakeholders and provide market leaders with details of the competitive landscape.
Years considered for this report:
Historical Years: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Period: 2021-2026
Global RNAi for Therapeutic Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries
Table of Content
1 RNAi for Therapeutic Market Definition and Overview
1.1 Objectives of the Study
1.2 Overview of RNAi for Therapeutic
1.3 RNAi for Therapeutic Market Scope and Market Size Estimation
1.4 Market Segmentation
1.4.1 Types of RNAi for Therapeutic
1.4.2 Applications of RNAi for Therapeutic
1.5 Market Exchange Rate
2 Research Method and Logic
2.1 Methodology
2.2 Research Data Source
3 Market Competition Analysis
3.1 Benitec Biopharma Market Performance Analysis
3.1.1 Benitec Biopharma Basic Information
3.1.2 Product and Service Analysis
3.1.3 Strategies for Company to Deal with the Impact of COVID-19
3.1.4 Benitec Biopharma Sales, Value, Price, Gross Margin 2016-2021
3.2 AstraZeneca Market Performance Analysis
3.2.1 AstraZeneca Basic Information
3.2.2 Product and Service Analysis
3.2.3 Strategies for Company to Deal with the Impact of COVID-19
3.2.4 AstraZeneca Sales, Value, Price, Gross Margin 2016-2021
3.3 Bayer Heathcare Market Performance Analysis
3.3.1 Bayer Heathcare Basic Information
3.3.2 Product and Service Analysis
3.3.3 Strategies for Company to Deal with the Impact of COVID-19
3.3.4 Bayer Heathcare Sales, Value, Price, Gross Margin 2016-2021
3.4 Ensysce Biosciences Market Performance Analysis
3.4.1 Ensysce Biosciences Basic Information
3.4.2 Product and Service Analysis
3.4.3 Strategies for Company to Deal with the Impact of COVID-19
3.4.4 Ensysce Biosciences Sales, Value, Price, Gross Margin 2016-2021
3.5 Ascletis Pharmaceuticals Market Performance Analysis
3.5.1 Ascletis Pharmaceuticals Basic Information
3.5.2 Product and Service Analysis
3.5.3 Strategies for Company to Deal with the Impact of COVID-19
3.5.4 Ascletis Pharmaceuticals Sales, Value, Price, Gross Margin 2016-2021
3.6 Tekmira Pharmaceuticals. Market Performance Analysis
3.6.1 Tekmira Pharmaceuticals. Basic Information
3.6.2 Product and Service Analysis
3.6.3 Strategies for Company to Deal with the Impact of COVID-19
3.6.4 Tekmira Pharmaceuticals. Sales, Value, Price, Gross Margin 2016-2021
3.7 GeneCopoeia Market Performance Analysis
3.7.1 GeneCopoeia Basic Information
3.7.2 Product and Service Analysis
3.7.3 Strategies for Company to Deal with the Impact of COVID-19
3.7.4 GeneCopoeia Sales, Value, Price, Gross Margin 2016-2021
3.8 Celgene Market Performance Analysis
3.8.1 Celgene Basic Information
3.8.2 Product and Service Analysis
3.8.3 Strategies for Company to Deal with the Impact of COVID-19
3.8.4 Celgene Sales, Value, Price, Gross Margin 2016-2021
3.9 Biogazelle Market Performance Analysis
3.9.1 Biogazelle Basic Information
3.9.2 Product and Service Analysis
3.9.3 Strategies for Company to Deal with the Impact of COVID-19
3.9.4 Biogazelle Sales, Value, Price, Gross Margin 2016-2021
3.10 RXi Pharmaceuticals Market Performance Analysis
3.10.1 RXi Pharmaceuticals Basic Information
3.10.2 Product and Service Analysis
3.10.3 Strategies for Company to Deal with the Impact of COVID-19
3.10.4 RXi Pharmaceuticals Sales, Value, Price, Gross Margin 2016-2021
3.11 Roche Innovation Center Copenhagen (formerly Santaris Pharma) Market Performance Analysis
3.11.1 Roche Innovation Center Copenhagen (formerly Santaris Pharma) Basic Information
3.11.2 Product and Service Analysis
3.11.3 Strategies for Company to Deal with the Impact of COVID-19
3.11.4 Roche Innovation Center Copenhagen (formerly Santaris Pharma) Sales, Value, Price, Gross Margin 2016-2021
3.12 Celsion Corporation Market Performance Analysis
3.12.1 Celsion Corporation Basic Information
3.12.2 Product and Service Analysis
3.12.3 Strategies for Company to Deal with the Impact of COVID-19
3.12.4 Celsion Corporation Sales, Value, Price, Gross Margin 2016-2021
3.13 Arrowhead Research Market Performance Analysis
3.13.1 Arrowhead Research Basic Information
3.13.2 Product and Service Analysis
3.13.3 Strategies for Company to Deal with the Impact of COVID-19
3.13.4 Arrowhead Research Sales, Value, Price, Gross Margin 2016-2021
3.14 Gradalis Incorporated Market Performance Analysis
3.14.1 Gradalis Incorporated Basic Information
3.14.2 Product and Service Analysis
3.14.3 Strategies for Company to Deal with the Impact of COVID-19
3.14.4 Gradalis Incorporated Sales, Value, Price, Gross Margin 2016-2021
3.15 Silenseed Market Performance Analysis
3.15.1 Silenseed Basic Information
3.15.2 Product and Service Analysis
3.15.3 Strategies for Company to Deal with the Impact of COVID-19
3.15.4 Silenseed Sales, Value, Price, Gross Margin 2016-2021
3.16 Astellas Pharma Market Performance Analysis
3.16.1 Astellas Pharma Basic Information
3.16.2 Product and Service Analysis
3.16.3 Strategies for Company to Deal with the Impact of COVID-19
3.16.4 Astellas Pharma Sales, Value, Price, Gross Margin 2016-2021
3.17 Silence Therapeutics Market Performance Analysis
3.17.1 Silence Therapeutics Basic Information
3.17.2 Product and Service Analysis
3.17.3 Strategies for Company to Deal with the Impact of COVID-19
3.17.4 Silence Therapeutics Sales, Value, Price, Gross Margin 2016-2021
3.18 Quark Pharmaceuticals Market Performance Analysis
3.18.1 Quark Pharmaceuticals Basic Information
3.18.2 Product and Service Analysis
3.18.3 Strategies for Company to Deal with the Impact of COVID-19
3.18.4 Quark Pharmaceuticals Sales, Value, Price, Gross Margin 2016-2021
3.19 BioSpring Market Performance Analysis
3.19.1 BioSpring Basic Information
3.19.2 Product and Service Analysis
3.19.3 Strategies for Company to Deal with the Impact of COVID-19
3.19.4 BioSpring Sales, Value, Price, Gross Margin 2016-2021
3.20 Creative Animodel Market Performance Analysis
3.20.1 Creative Animodel Basic Information
3.20.2 Product and Service Analysis
3.20.3 Strategies for Company to Deal with the Impact of COVID-19
3.20.4 Creative Animodel Sales, Value, Price, Gross Margin 2016-2021
3.21 Sylentis Market Performance Analysis
3.21.1 Sylentis Basic Information
3.21.2 Product and Service Analysis
3.21.3 Strategies for Company to Deal with the Impact of COVID-19
3.21.4 Sylentis Sales, Value, Price, Gross Margin 2016-2021
3.22 Calando Pharmaceuticals Market Performance Analysis
3.22.1 Calando Pharmaceuticals Basic Information
3.22.2 Product and Service Analysis
3.22.3 Strategies for Company to Deal with the Impact of COVID-19
3.22.4 Calando Pharmaceuticals Sales, Value, Price, Gross Margin 2016-2021
3.23 CombiMatrix Market Performance Analysis
3.23.1 CombiMatrix Basic Information
3.23.2 Product and Service Analysis
3.23.3 Strategies for Company to Deal with the Impact of COVID-19
3.23.4 CombiMatrix Sales, Value, Price, Gross Margin 2016-2021
3.24 Alnylam Pharmaceuticals Market Performance Analysis
3.24.1 Alnylam Pharmaceuticals Basic Information
3.24.2 Product and Service Analysis
3.24.3 Strategies for Company to Deal with the Impact of COVID-19
3.24.4 Alnylam Pharmaceuticals Sales, Value, Price, Gross Margin 2016-2021
4 Market Segment by Type, Historical Data and Market Forecasts
4.1 Global RNAi for Therapeutic Production and Value by Type
4.1.1 Global RNAi for Therapeutic Production by Type 2016-2021
4.1.2 Global RNAi for Therapeutic Market Value by Type 2016-2021
4.2 Global RNAi for Therapeutic Market Production, Value and Growth Rate by Type 2016-2021
4.2.1 siRNA Market Production, Value and Growth Rate
4.2.2 miRNA Market Production, Value and Growth Rate
4.2.3 shRNA Market Production, Value and Growth Rate
4.3 Global RNAi for Therapeutic Production and Value Forecast by Type
4.3.1 Global RNAi for Therapeutic Production Forecast by Type 2021-2026
4.3.2 Global RNAi for Therapeutic Market Value Forecast by Type 2021-2026
4.4 Global RNAi for Therapeutic Market Production, Value and Growth Rate by Type Forecast 2021-2026
4.4.1 siRNA Market Production, Value and Growth Rate Forecast
4.4.2 miRNA Market Production, Value and Growth Rate Forecast
4.4.3 shRNA Market Production, Value and Growth Rate Forecast
5 Market Segment by Application, Historical Data and Market Forecasts
5.1 Global RNAi for Therapeutic Consumption and Value by Application
5.1.1 Global RNAi for Therapeutic Consumption by Application 2016-2021
5.1.2 Global RNAi for Therapeutic Market Value by Application 2016-2021
5.2 Global RNAi for Therapeutic Market Consumption, Value and Growth Rate by Application 2016-2021
5.2.1 Cancer Market Consumption, Value and Growth Rate
5.2.2 Cardiovascular Market Consumption, Value and Growth Rate
5.2.3 HBV Market Consumption, Value and Growth Rate
5.2.4 Others Market Consumption, Value and Growth Rate
5.3 Global RNAi for Therapeutic Consumption and Value Forecast by Application
5.3.1 Global RNAi for Therapeutic Consumption Forecast by Application 2021-2026
5.3.2 Global RNAi for Therapeutic Market Value Forecast by Application 2021-2026
5.4 Global RNAi for Therapeutic Market Consumption, Value and Growth Rate by Application Forecast 2021-2026
5.4.1 Cancer Market Consumption, Value and Growth Rate Forecast
5.4.2 Cardiovascular Market Consumption, Value and Growth Rate Forecast
5.4.3 HBV Market Consumption, Value and Growth Rate Forecast
5.4.4 Others Market Consumption, Value and Growth Rate Forecast
6 Global RNAi for Therapeutic by Region, Historical Data and Market Forecasts
6.1 Global RNAi for Therapeutic Sales by Region 2016-2021
6.2 Global RNAi for Therapeutic Market Value by Region 2016-2021
6.3 Global RNAi for Therapeutic Market Sales, Value and Growth Rate by Region 2016-2021
6.3.1 North America
6.3.2 Europe
6.3.3 Asia Pacific
6.3.4 South America
6.3.5 Middle East and Africa
6.4 Global RNAi for Therapeutic Sales Forecast by Region 2021-2026
6.5 Global RNAi for Therapeutic Market Value Forecast by Region 2021-2026
6.6 Global RNAi for Therapeutic Market Sales, Value and Growth Rate Forecast by Region 2021-2026
6.6.1 North America
6.6.2 Europe
6.6.3 Asia Pacific
6.6.4 South America
6.6.5 Middle East and Africa
7 United State Market Size Analysis 2016-2026
7.1 United State RNAi for Therapeutic Value and Market Growth 2016-2021
7.2 United State RNAi for Therapeutic Sales and Market Growth 2016-2021
7.3 United State RNAi for Therapeutic Market Value Forecast 2021-2026
8 Canada Market Size Analysis 2016-2026
8.1 Canada RNAi for Therapeutic Value and Market Growth 2016-2021
8.2 Canada RNAi for Therapeutic Sales and Market Growth 2016-2021
8.3 Canada RNAi for Therapeutic Market Value Forecast 2021-2026
9 Germany Market Size Analysis 2016-2026
9.1 Germany RNAi for Therapeutic Value and Market Growth 2016-2021
9.2 Germany RNAi for Therapeutic Sales and Market Growth 2016-2021
9.3 Germany RNAi for Therapeutic Market Value Forecast 2021-2026
10 UK Market Size Analysis 2016-2026
10.1 UK RNAi for Therapeutic Value and Market Growth 2016-2021
10.2 UK RNAi for Therapeutic Sales and Market Growth 2016-2021
10.3 UK RNAi for Therapeutic Market Value Forecast 2021-2026
11 France Market Size Analysis 2016-2026
11.1 France RNAi for Therapeutic Value and Market Growth 2016-2021
11.2 France RNAi for Therapeutic Sales and Market Growth 2016-2021
11.3 France RNAi for Therapeutic Market Value Forecast 2021-2026
12 Italy Market Size Analysis 2016-2026
12.1 Italy RNAi for Therapeutic Value and Market Growth 2016-2021
12.2 Italy RNAi for Therapeutic Sales and Market Growth 2016-2021
12.3 Italy RNAi for Therapeutic Market Value Forecast 2021-2026
13 Spain Market Size Analysis 2016-2026
13.1 Spain RNAi for Therapeutic Value and Market Growth 2016-2021
13.2 Spain RNAi for Therapeutic Sales and Market Growth 2016-2021
13.3 Spain RNAi for Therapeutic Market Value Forecast 2021-2026
14 Russia Market Size Analysis 2016-2026
14.1 Russia RNAi for Therapeutic Value and Market Growth 2016-2021
14.2 Russia RNAi for Therapeutic Sales and Market Growth 2016-2021
14.3 Russia RNAi for Therapeutic Market Value Forecast 2021-2026
15 China Market Size Analysis 2016-2026
15.1 China RNAi for Therapeutic Value and Market Growth 2016-2021
15.2 China RNAi for Therapeutic Sales and Market Growth 2016-2021
15.3 China RNAi for Therapeutic Market Value Forecast 2021-2026
16 Japan Market Size Analysis 2016-2026
16.1 Japan RNAi for Therapeutic Value and Market Growth 2016-2021
16.2 Japan RNAi for Therapeutic Sales and Market Growth 2016-2021
16.3 Japan RNAi for Therapeutic Market Value Forecast 2021-2026
17 South Korea Market Size Analysis 2016-2026
17.1 South Korea RNAi for Therapeutic Value and Market Growth 2016-2021
17.2 South Korea RNAi for Therapeutic Sales and Market Growth 2016-2021
17.3 South Korea RNAi for Therapeutic Market Value Forecast 2021-2026
18 Australia Market Size Analysis 2016-2026
18.1 Australia RNAi for Therapeutic Value and Market Growth 2016-2021
18.2 Australia RNAi for Therapeutic Sales and Market Growth 2016-2021
18.3 Australia RNAi for Therapeutic Market Value Forecast 2021-2026
19 Thailand Market Size Analysis 2016-2026
19.1 Thailand RNAi for Therapeutic Value and Market Growth 2016-2021
19.2 Thailand RNAi for Therapeutic Sales and Market Growth 2016-2021
19.3 Thailand RNAi for Therapeutic Market Value Forecast 2021-2026
20 Brazil Market Size Analysis 2016-2026
20.1 Brazil RNAi for Therapeutic Value and Market Growth 2016-2021
20.2 Brazil RNAi for Therapeutic Sales and Market Growth 2016-2021
20.3 Brazil RNAi for Therapeutic Market Value Forecast 2021-2026
21 Argentina Market Size Analysis 2016-2026
21.1 Argentina RNAi for Therapeutic Value and Market Growth 2016-2021
21.2 Argentina RNAi for Therapeutic Sales and Market Growth 2016-2021
21.3 Argentina RNAi for Therapeutic Market Value Forecast 2021-2026
22 Chile Market Size Analysis 2016-2026
22.1 Chile RNAi for Therapeutic Value and Market Growth 2016-2021
22.2 Chile RNAi for Therapeutic Sales and Market Growth 2016-2021
22.3 Chile RNAi for Therapeutic Market Value Forecast 2021-2026
23 South Africa Market Size Analysis 2016-2026
23.1 South Africa RNAi for Therapeutic Value and Market Growth 2016-2021
23.2 South Africa RNAi for Therapeutic Sales and Market Growth 2016-2021
23.3 South Africa RNAi for Therapeutic Market Value Forecast 2021-2026
24 Egypt Market Size Analysis 2016-2026
24.1 Egypt RNAi for Therapeutic Value and Market Growth 2016-2021
24.2 Egypt RNAi for Therapeutic Sales and Market Growth 2016-2021
24.3 Egypt RNAi for Therapeutic Market Value Forecast 2021-2026
25 UAE Market Size Analysis 2016-2026
25.1 UAE RNAi for Therapeutic Value and Market Growth 2016-2021
25.2 UAE RNAi for Therapeutic Sales and Market Growth 2016-2021
25.3 UAE RNAi for Therapeutic Market Value Forecast 2021-2026
26 Saudi Arabia Market Size Analysis 2016-2026
26.1 Saudi Arabia RNAi for Therapeutic Value and Market Growth 2016-2021
26.2 Saudi Arabia RNAi for Therapeutic Sales and Market Growth 2016-2021
26.3 Saudi Arabia RNAi for Therapeutic Market Value Forecast 2021-2026
27 Market Dynamic Analysis and Development Suggestions
27.1 Market Drivers
27.2 Market Development Constraints
27.3 PEST Analysis
27.3.1 Political Factors
27.3.2 Economic Factors
27.3.3 Social Factors
27.3.4 Technological Factors
27.4 Industry Trends Under COVID-19
27.4.1 Risk Assessment on COVID-19
27.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
27.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
27.5 Market Entry Strategy Analysis
27.5.1 Market Definition
27.5.2 Client
27.5.3 Distribution Model
27.5.4 Product Messaging and Positioning
27.5.5 Price
27.6 Advice on Entering the Market
List of Tables and Figures
Market Size Comparison Before and After the COVID-19 Outbreak of Major Company
Global RNAi for Therapeutic Market Size in 2020 and 2026
Market Size Comparison Before and After the COVID-19 Outbreak of Major Countries
Figure Global RNAi for Therapeutic Value (M USD) Segment by Type from 2016-2021
Figure Global RNAi for Therapeutic Market (M USD) Share by Types in 2020
Table Different Applications of RNAi for Therapeutic
Figure Global RNAi for Therapeutic Value (M USD) Segment by Applications from 2016-2021
Figure Global RNAi for Therapeutic Market Share by Applications in 2020
Table Market Exchange Rate
Table Benitec Biopharma Basic Information
Table Product and Service Analysis
Table Benitec Biopharma Sales, Value, Price, Gross Margin 2016-2021
Table AstraZeneca Basic Information
Table Product and Service Analysis
Table AstraZeneca Sales, Value, Price, Gross Margin 2016-2021
Table Bayer Heathcare Basic Information
Table Product and Service Analysis
Table Bayer Heathcare Sales, Value, Price, Gross Margin 2016-2021
Table Ensysce Biosciences Basic Information
Table Product and Service Analysis
Table Ensysce Biosciences Sales, Value, Price, Gross Margin 2016-2021
Table Ascletis Pharmaceuticals Basic Information
Table Product and Service Analysis
Table Ascletis Pharmaceuticals Sales, Value, Price, Gross Margin 2016-2021
Table Tekmira Pharmaceuticals. Basic Information
Table Product and Service Analysis
Table Tekmira Pharmaceuticals. Sales, Value, Price, Gross Margin 2016-2021
Table GeneCopoeia Basic Information
Table Product and Service Analysis
Table GeneCopoeia Sales, Value, Price, Gross Margin 2016-2021
Table Celgene Basic Information
Table Product and Service Analysis
Table Celgene Sales, Value, Price, Gross Margin 2016-2021
Table Biogazelle Basic Information
Table Product and Service Analysis
Table Biogazelle Sales, Value, Price, Gross Margin 2016-2021
Table RXi Pharmaceuticals Basic Information
Table Product and Service Analysis
Table RXi Pharmaceuticals Sales, Value, Price, Gross Margin 2016-2021
Table Roche Innovation Center Copenhagen (formerly Santaris Pharma) Basic Information
Table Product and Service Analysis
Table Roche Innovation Center Copenhagen (formerly Santaris Pharma) Sales, Value, Price, Gross Margin 2016-2021
Table Celsion Corporation Basic Information
Table Product and Service Analysis
Table Celsion Corporation Sales, Value, Price, Gross Margin 2016-2021
Table Arrowhead Research Basic Information
Table Product and Service Analysis
Table Arrowhead Research Sales, Value, Price, Gross Margin 2016-2021
Table Gradalis Incorporated Basic Information
Table Product and Service Analysis
Table Gradalis Incorporated Sales, Value, Price, Gross Margin 2016-2021
Table Silenseed Basic Information
Table Product and Service Analysis
Table Silenseed Sales, Value, Price, Gross Margin 2016-2021
Table Astellas Pharma Basic Information
Table Product and Service Analysis
Table Astellas Pharma Sales, Value, Price, Gross Margin 2016-2021
Table Silence Therapeutics Basic Information
Table Product and Service Analysis
Table Silence Therapeutics Sales, Value, Price, Gross Margin 2016-2021
Table Quark Pharmaceuticals Basic Information
Table Product and Service Analysis
Table Quark Pharmaceuticals Sales, Value, Price, Gross Margin 2016-2021
Table BioSpring Basic Information
Table Product and Service Analysis
Table BioSpring Sales, Value, Price, Gross Margin 2016-2021
Table Creative Animodel Basic Information
Table Product and Service Analysis
Table Creative Animodel Sales, Value, Price, Gross Margin 2016-2021
Table Sylentis Basic Information
Table Product and Service Analysis
Table Sylentis Sales, Value, Price, Gross Margin 2016-2021
Table Calando Pharmaceuticals Basic Information
Table Product and Service Analysis
Table Calando Pharmaceuticals Sales, Value, Price, Gross Margin 2016-2021
Table CombiMatrix Basic Information
Table Product and Service Analysis
Table CombiMatrix Sales, Value, Price, Gross Margin 2016-2021
Table Alnylam Pharmaceuticals Basic Information
Table Product and Service Analysis
Table Alnylam Pharmaceuticals Sales, Value, Price, Gross Margin 2016-2021
Table Global RNAi for Therapeutic Consumption by Type 2016-2021
Table Global RNAi for Therapeutic Consumption Share by Type 2016-2021
Table Global RNAi for Therapeutic Market Value (M USD) by Type 2016-2021
Table Global RNAi for Therapeutic Market Value Share by Type 2016-2021
Figure Global RNAi for Therapeutic Market Production and Growth Rate of siRNA 2016-2021
Figure Global RNAi for Therapeutic Market Value and Growth Rate of siRNA 2016-2021
Figure Global RNAi for Therapeutic Market Production and Growth Rate of miRNA 2016-2021
Figure Global RNAi for Therapeutic Market Value and Growth Rate of miRNA 2016-2021
Figure Global RNAi for Therapeutic Market Production and Growth Rate of shRNA 2016-2021
Figure Global RNAi for Therapeutic Market Value and Growth Rate of shRNA 2016-2021
Table Global RNAi for Therapeutic Consumption Forecast by Type 2021-2026
Table Global RNAi for Therapeutic Consumption Share Forecast by Type 2021-2026
Table Global RNAi for Therapeutic Market Value (M USD) Forecast by Type 2021-2026
Table Global RNAi for Therapeutic Market Value Share Forecast by Type 2021-2026
Figure Global RNAi for Therapeutic Market Production and Growth Rate of siRNA Forecast 2021-2026
Figure Global RNAi for Therapeutic Market Value and Growth Rate of siRNA Forecast 2021-2026
Figure Global RNAi for Therapeutic Market Production and Growth Rate of miRNA Forecast 2021-2026
Figure Global RNAi for Therapeutic Market Value and Growth Rate of miRNA Forecast 2021-2026
Figure Global RNAi for Therapeutic Market Production and Growth Rate of shRNA Forecast 2021-2026
Figure Global RNAi for Therapeutic Market Value and Growth Rate of shRNA Forecast 2021-2026
Table Global RNAi for Therapeutic Consumption by Application 2016-2021
Table Global RNAi for Therapeutic Consumption Share by Application 2016-2021
Table Global RNAi for Therapeutic Market Value (M USD) by Application 2016-2021
Table Global RNAi for Therapeutic Market Value Share by Application 2016-2021
Figure Global RNAi for Therapeutic Market Consumption and Growth Rate of Cancer 2016-2021
Figure Global RNAi for Therapeutic Market Value and Growth Rate of Cancer 2016-2021Figure Global RNAi for Therapeutic Market Consumption and Growth Rate of Cardiovascular 2016-2021
Figure Global RNAi for Therapeutic Market Value and Growth Rate of Cardiovascular 2016-2021Figure Global RNAi for Therapeutic Market Consumption and Growth Rate of HBV 2016-2021
Figure Global RNAi for Therapeutic Market Value and Growth Rate of HBV 2016-2021Figure Global RNAi for Therapeutic Market Consumption and Growth Rate of Others 2016-2021
Figure Global RNAi for Therapeutic Market Value and Growth Rate of Others 2016-2021Table Global RNAi for Therapeutic Consumption Forecast by Application 2021-2026
Table Global RNAi for Therapeutic Consumption Share Forecast by Application 2021-2026
Table Global RNAi for Therapeutic Market Value (M USD) Forecast by Application 2021-2026
Table Global RNAi for Therapeutic Market Value Share Forecast by Application 2021-2026
Figure Global RNAi for Therapeutic Market Consumption and Growth Rate of Cancer Forecast 2021-2026
Figure Global RNAi for Therapeutic Market Value and Growth Rate of Cancer Forecast 2021-2026
Figure Global RNAi for Therapeutic Market Consumption and Growth Rate of Cardiovascular Forecast 2021-2026
Figure Global RNAi for Therapeutic Market Value and Growth Rate of Cardiovascular Forecast 2021-2026
Figure Global RNAi for Therapeutic Market Consumption and Growth Rate of HBV Forecast 2021-2026
Figure Global RNAi for Therapeutic Market Value and Growth Rate of HBV Forecast 2021-2026
Figure Global RNAi for Therapeutic Market Consumption and Growth Rate of Others Forecast 2021-2026
Figure Global RNAi for Therapeutic Market Value and Growth Rate of Others Forecast 2021-2026
Table Global RNAi for Therapeutic Sales by Region 2016-2021
Table Global RNAi for Therapeutic Sales Share by Region 2016-2021
Table Global RNAi for Therapeutic Market Value (M USD) by Region 2016-2021
Table Global RNAi for Therapeutic Market Value Share by Region 2016-2021
Figure North America RNAi for Therapeutic Sales and Growth Rate 2016-2021
Figure North America RNAi for Therapeutic Market Value (M USD) and Growth Rate 2016-2021
Figure Europe RNAi for Therapeutic Sales and Growth Rate 2016-2021
Figure Europe RNAi for Therapeutic Market Value (M USD) and Growth Rate 2016-2021
Figure Asia Pacific RNAi for Therapeutic Sales and Growth Rate 2016-2021
Figure Asia Pacific RNAi for Therapeutic Market Value (M USD) and Growth Rate 2016-2021
Figure South America RNAi for Therapeutic Sales and Growth Rate 2016-2021
Figure South America RNAi for Therapeutic Market Value (M USD) and Growth Rate 2016-2021
Figure Middle East and Africa RNAi for Therapeutic Sales and Growth Rate 2016-2021
Figure Middle East and Africa RNAi for Therapeutic Market Value (M USD) and Growth Rate 2016-2021
Table Global RNAi for Therapeutic Sales Forecast by Region 2021-2026
Table Global RNAi for Therapeutic Sales Share Forecast by Region 2021-2026
Table Global RNAi for Therapeutic Market Value (M USD) Forecast by Region 2021-2026
Table Global RNAi for Therapeutic Market Value Share Forecast by Region 2021-2026
Figure North America RNAi for Therapeutic Sales and Growth Rate Forecast 2021-2026
Figure North America RNAi for Therapeutic Market Value (M USD) and Growth Rate Forecast 2021-2026
Figure Europe RNAi for Therapeutic Sales and Growth Rate Forecast 2021-2026
Figure Europe RNAi for Therapeutic Market Value (M USD) and Growth Rate Forecast 2021-2026
Figure Asia Pacific RNAi for Therapeutic Sales and Growth Rate Forecast 2021-2026
Figure Asia Pacific RNAi for Therapeutic Market Value (M USD) and Growth Rate Forecast 2021-2026
Figure South America RNAi for Therapeutic Sales and Growth Rate Forecast 2021-2026
Figure South America RNAi for Therapeutic Market Value (M USD) and Growth Rate Forecast 2021-2026
Figure Middle East and Africa RNAi for Therapeutic Sales and Growth Rate Forecast 2021-2026
Figure Middle East and Africa RNAi for Therapeutic Market Value (M USD) and Growth Rate Forecast 2021-2026
Figure United State RNAi for Therapeutic Value (M USD) and Market Growth 2016-2021
Figure United State RNAi for Therapeutic Sales and Market Growth 2016-2021
Figure United State RNAi for Therapeutic Market Value and Growth Rate Forecast 2021-2026
Figure Canada RNAi for Therapeutic Value (M USD) and Market Growth 2016-2021
Figure Canada RNAi for Therapeutic Sales and Market Growth 2016-2021
Figure Canada RNAi for Therapeutic Market Value and Growth Rate Forecast 2021-2026
Figure Germany RNAi for Therapeutic Value (M USD) and Market Growth 2016-2021
Figure Germany RNAi for Therapeutic Sales and Market Growth 2016-2021
Figure Germany RNAi for Therapeutic Market Value and Growth Rate Forecast 2021-2026
Figure UK RNAi for Therapeutic Value (M USD) and Market Growth 2016-2021
Figure UK RNAi for Therapeutic Sales and Market Growth 2016-2021
Figure UK RNAi for Therapeutic Market Value and Growth Rate Forecast 2021-2026
Figure France RNAi for Therapeutic Value (M USD) and Market Growth 2016-2021
Figure France RNAi for Therapeutic Sales and Market Growth 2016-2021
Figure France RNAi for Therapeutic Market Value and Growth Rate Forecast 2021-2026
Figure Italy RNAi for Therapeutic Value (M USD) and Market Growth 2016-2021
Figure Italy RNAi for Therapeutic Sales and Market Growth 2016-2021
Figure Italy RNAi for Therapeutic Market Value and Growth Rate Forecast 2021-2026
Figure Spain RNAi for Therapeutic Value (M USD) and Market Growth 2016-2021
Figure Spain RNAi for Therapeutic Sales and Market Growth 2016-2021
Figure Spain RNAi for Therapeutic Market Value and Growth Rate Forecast 2021-2026
Figure Russia RNAi for Therapeutic Value (M USD) and Market Growth 2016-2021
Figure Russia RNAi for Therapeutic Sales and Market Growth 2016-2021
Figure Russia RNAi for Therapeutic Market Value and Growth Rate Forecast 2021-2026
Figure China RNAi for Therapeutic Value (M USD) and Market Growth 2016-2021
Figure China RNAi for Therapeutic Sales and Market Growth 2016-2021
Figure China RNAi for Therapeutic Market Value and Growth Rate Forecast 2021-2026
Figure Japan RNAi for Therapeutic Value (M USD) and Market Growth 2016-2021
Figure Japan RNAi for Therapeutic Sales and Market Growth 2016-2021
Figure Japan RNAi for Therapeutic Market Value and Growth Rate Forecast 2021-2026
Figure South Korea RNAi for Therapeutic Value (M USD) and Market Growth 2016-2021
Figure South Korea RNAi for Therapeutic Sales and Market Growth 2016-2021
Figure South Korea RNAi for Therapeutic Market Value and Growth Rate Forecast 2021-2026
Figure Australia RNAi for Therapeutic Value (M USD) and Market Growth 2016-2021
Figure Australia RNAi for Therapeutic Sales and Market Growth 2016-2021
Figure Australia RNAi for Therapeutic Market Value and Growth Rate Forecast 2021-2026
Figure Thailand RNAi for Therapeutic Value (M USD) and Market Growth 2016-2021
Figure Thailand RNAi for Therapeutic Sales and Market Growth 2016-2021
Figure Thailand RNAi for Therapeutic Market Value and Growth Rate Forecast 2021-2026
Figure Brazil RNAi for Therapeutic Value (M USD) and Market Growth 2016-2021
Figure Brazil RNAi for Therapeutic Sales and Market Growth 2016-2021
Figure Brazil RNAi for Therapeutic Market Value and Growth Rate Forecast 2021-2026
Figure Argentina RNAi for Therapeutic Value (M USD) and Market Growth 2016-2021
Figure Argentina RNAi for Therapeutic Sales and Market Growth 2016-2021
Figure Argentina RNAi for Therapeutic Market Value and Growth Rate Forecast 2021-2026
Figure Chile RNAi for Therapeutic Value (M USD) and Market Growth 2016-2021
Figure Chile RNAi for Therapeutic Sales and Market Growth 2016-2021
Figure Chile RNAi for Therapeutic Market Value and Growth Rate Forecast 2021-2026
Figure South Africa RNAi for Therapeutic Value (M USD) and Market Growth 2016-2021
Figure South Africa RNAi for Therapeutic Sales and Market Growth 2016-2021
Figure South Africa RNAi for Therapeutic Market Value and Growth Rate Forecast 2021-2026
Figure Egypt RNAi for Therapeutic Value (M USD) and Market Growth 2016-2021
Figure Egypt RNAi for Therapeutic Sales and Market Growth 2016-2021
Figure Egypt RNAi for Therapeutic Market Value and Growth Rate Forecast 2021-2026
Figure UAE RNAi for Therapeutic Value (M USD) and Market Growth 2016-2021
Figure UAE RNAi for Therapeutic Sales and Market Growth 2016-2021
Figure UAE RNAi for Therapeutic Market Value and Growth Rate Forecast 2021-2026
Figure Saudi Arabia RNAi for Therapeutic Value (M USD) and Market Growth 2016-2021
Figure Saudi Arabia RNAi for Therapeutic Sales and Market Growth 2016-2021
Figure Saudi Arabia RNAi for Therapeutic Market Value and Growth Rate Forecast 2021-2026
Table Market Drivers
Table Market Development Constraints
Table PEST Analysis
Global Targeted RNA Sequencing Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 71
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing The ability to detect both known and novel gene fusion partners in many sample types.
In The report, we ......
Global Targeted RNA Sequencing Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 87
According to our LPI (LP Information) latest study, the global Targeted RNA Sequencing market size was valued at US$ 1761.4 million in 2023. With growing demand in downstream market, the Targeted RNA Sequencing is forecast to a readjusted size of US$ 7649.2 million by 2030 with a CAGR of 23.3% during review period.
The research report highlights the growth potential of the global Targeted RNA Sequencing market. Targeted RNA Sequencing are expected to show stable growth in the future mark......
Global Targeted RNA Sequencing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 94
According to our (Global Info Research) latest study, the global Targeted RNA Sequencing market size was valued at USD 1852.7 million in 2023 and is forecast to a readjusted size of USD 7255.4 million by 2030 with a CAGR of 21.5% during review period.
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or ......
Global Antisense and RNAi Therapeutics Market Research Report 2023, Forecast to 2028
Published: 26-Dec-2023 Price: US 2680 Onwards Pages: 133
Antisense therapy means the selective, sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. In contrast, RNA interference (RNAi) is triggered by double-stranded RNA (dsRNA) and causes sequence-specific mRNA degradation of single-stranded target RNAs in response to dsRNA.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (millio......
Global Antisense and RNAi Therapeutics Professional Survey Report 2023, Forecast to 2028
Published: 26-Dec-2023 Price: US 3280 Onwards Pages: 101
Antisense therapy means the selective, sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. In contrast, RNA interference (RNAi) is triggered by double-stranded RNA (dsRNA) and causes sequence-specific mRNA degradation of single-stranded target RNAs in response to dsRNA.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (millio......
Global Targeted RNA Sequencing Market Research Report 2023, Forecast to 2028
Published: 13-Nov-2023 Price: US 2680 Onwards Pages: 137
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......
Global Targeted RNA Sequencing Professional Survey Report 2023, Forecast to 2028
Published: 13-Nov-2023 Price: US 3280 Onwards Pages: 100
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......
Global RNAi for Therapeutic Market Status and Outlook 2023-2028
Published: 08-Nov-2023 Price: US 3160 Onwards Pages: 106
RNAi is a fundamental cellular mechanism for silencing gene expression that can be harnessed for the development of new drugs
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......
Global RNAi for Therapeutic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 24-Oct-2023 Price: US 3380 Onwards Pages: 104
Market Overview of Global RNAi for Therapeutic market:
According to our latest research, the global RNAi for Therapeutic market looks promising in the next 5 years. As of 2022, the global RNAi for Therapeutic market was estimated at USD 260.55 million, and it's anticipated to reach USD 3633.33 million in 2028, with a CAGR of 55.14% during the forecast years.
RNA interference (RNAi) is a collection of small RNA directed mechanisms that result in sequence specific inhibition of......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
